Q3 2025 · 13F-HR
PFIZER INC (PFE)holdings as filed
Filed 2025-11-13 · accession 0000078003-25-000161
$437.5M
Reported value
21
Positions
2025-09-30
Period end
The Brief · PFIZER INC (PFE) · Q3 2025
AI · grounded in 13F
PFIZER INC (PFE) established a new position in BIONTECH SE BNTX valued at $163.5M. The fund also initiated new stakes in ORIC PHARMACEUTICALS INC ORIC for $64.5M and TOURMALINE BIO INC TRML for $60.8M. Additional new positions include ARVINAS INC ARVN, ALLOGENE THERAPEUTICS INC ALLO, and CELCUITY INC CELC.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 09075V102 | BNTX | BIONTECH SE | $163.5M | 37.4% | 1,658,361 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $64.5M | 14.7% | 5,376,344 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $60.8M | 13.9% | 1,272,214 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $29.5M | 6.73% | 3,457,815 | Common | SOLE |
| 019770106 | ALLO | ALLOGENE THERAPEUTICS INC | $27.3M | 6.25% | 22,032,040 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $17.3M | 3.95% | 349,406 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $15.6M | 3.57% | 7,032,770 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $13.7M | 3.14% | 1,875,000 | Common | SHARED |
| G9TY5A101 | ZURA | ZURA BIO LTD | $12.9M | 2.94% | 2,970,022 | Common | SOLE |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $10.9M | 2.50% | 4,690,431 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $7.6M | 1.73% | 505,645 | Common | SOLE |
| 14147L108 | CRDF | CARDIFF ONCOLOGY INC | $5.0M | 1.14% | 2,411,575 | Common | SOLE |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $4.4M | 1.02% | 2,362,348 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $1.4M | 0.33% | 953,834 | Common | SOLE |
| 65343E207 | NXTC | NEXTCURE INC | $923,806 | 0.21% | 157,646 | Common | SOLE |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $908,425 | 0.21% | 715,295 | Common | SHARED |
| 746964105 | QTTB | Q32 BIO INC | $549,998 | 0.13% | 277,777 | Common | SOLE |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $319,925 | 0.07% | 1,675,000 | Common | SOLE |
| 097702203 | BOLT | BOLT BIOTHERAPEUTICS INC | $166,543 | 0.04% | 31,305 | Common | SHARED |
| 37611X209 | DNA | GINKGO BIOWORKS HOLDINGS INC | $42,690 | 0.01% | 2,928 | Common | SOLE |
| 81727U105 | SENS1GBP | SENSEONICS HLDGS INC | $18,934 | 0.00% | 43,426 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.